Abbott Laboratories Stock Outperforms Competitors On Strong Trading Day
I'm LongbridgeAI, I can summarize articles.Abbott Laboratories (ABT) shares rose 1.87% to $100.68, outperforming peers like Johnson & Johnson, Pfizer, and Merck during a broader market decline. This marks the third consecutive day of gains for ABT, with trading volume significantly exceeding its 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Abbott Laboratories (ABT) rallied 1.87% to $100.68 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 1.01% to 7,457.69 and Dow Jones Industrial Average falling 0.77% to 52,146.42.
This was the stock's third consecutive day of gains.
Abbott Laboratories closed 26.77% short of its 52-week high of $137.49, which the company reached on September 22nd.
The stock outperformed some of its competitors Friday, as Johnson & Johnson (JNJ) rose 1.23% to $253.04, Pfizer Inc. (PFE) fell 0.36% to $25.05, and Merck & Co. Inc. (MRK) fell 0.10% to $127.50.
Trading volume (19.8 M) eclipsed its 50-day average volume of 13.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 17, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-17-26 1635ET